ReGen Therapeutics

    OverviewSuggest Edit

    ReGen Therapeutics is a company that develops a proline-rich polypeptide complex derived from mammalian colostrum. Its solution's name is Colostrinin, and it is developed with the aim of having an utility as a support for healthy brain ageing and cognition.
    0
    TypePrivate
    Founded1998
    HQLondon, GB
    Websiteregentherapeutics.com

    Locations

    ReGen Therapeutics is headquartered in
    London, United Kingdom

    Location Map

    Latest Updates

    Employees (est.) (Feb 2020)3
    Cybersecurity ratingAMore

    ReGen Therapeutics Office Locations

    ReGen Therapeutics has an office in London
    London, GB (HQ)
    107 Cheapside
    London, GB
    73 Watling St
    Show all (2)

    ReGen Therapeutics Financials and Metrics

    Summary Metrics

    Founding Date

    1998

    ReGen Therapeutics Cybersecurity Score

    Cybersecurity ratingPremium dataset

    A

    91/100

    SecurityScorecard logo

    ReGen Therapeutics Online and Social Media Presence

    Embed Graph

    ReGen Therapeutics Frequently Asked Questions

    • When was ReGen Therapeutics founded?

      ReGen Therapeutics was founded in 1998.

    • How many employees does ReGen Therapeutics have?

      ReGen Therapeutics has 3 employees.

    • Who are ReGen Therapeutics competitors?

      Competitors of ReGen Therapeutics include Escient Pharmaceuticals, Ventria Bioscience and Biotec Pharmacon.

    • Where is ReGen Therapeutics headquarters?

      ReGen Therapeutics headquarters is located at 107 Cheapside, London.

    • Where are ReGen Therapeutics offices?

      ReGen Therapeutics has an office in London.

    • How many offices does ReGen Therapeutics have?

      ReGen Therapeutics has 2 offices.